Molecular Tests in Pancreatic Cancer: Critical Role of Molecular Testing, Expanding Access, and Adherence to the NCCN Guidelines for Pancreatic Cancer-Reference-Cited by-同舟云学术

Molecular Tests in Pancreatic Cancer: Critical Role of Molecular Testing, Expanding Access, and Adherence to the NCCN Guidelines for Pancreatic Cancer

Published:2024-07 Issue:5 Volume:22 Page:360-362
ISSN:1540-1405
Container-title:Journal of the National Comprehensive Cancer Network
language:
Short-container-title:

Author:

Jhala Nirag¹²,Petersen Jeffrey³⁴,Jhala Darshana³⁴

Affiliation:

1. Division of Oncology Pathology at Rutgers Cancer Institute, New Brunswick, NJ

2. Department of Pathology and Laboratory Medicine at Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ

3. Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA

4. Department of Pathology and Laboratory Medicine at Corporal Michael J. Crescenz Veteran Affairs Medical Center, Philadelphia, PA

Publisher

Harborside Press, LLC

Link

https://jnccn.org/downloadpdf/journals/jnccn/22/5/article-p360.xml

Reference14 articles.

1. NCCN Clinical Practice Guidelines in Oncology: Pancreatic Adenocarcinoma;Tempero MA

2. Compliance with the current NCCN Guidelines and its critical role in pancreatic adenocarcinoma;Petersen JM,2023

3. Bridging the divide: from universal germline testing guidance to real-world implementation in pancreatic cancer care;Singh H

4. Hereditary cancer clinics improve adherence to National Comprehensive Cancer Network germline testing guidelines for pancreatic cancer;Rosso C,2024

5. Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial [published correction appears in;Pishvaian MJ,2020